Plain-English translation of NCT06535854 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Coronary Artery Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The Prevail Global study is testing a new medical device called the Prevail Drug-Coated Balloon to treat blocked heart arteries. Depending on which group you join, you'll either receive this treatment for a blockage that has returned after previous stent placement, or for a new blockage in a small heart vessel. Researchers will compare how well this new balloon treatment works compared to other available options.
Some patients experience their heart arteries becoming blocked again after receiving a stent (a small metal tube placed to keep arteries open), and others have blockages in very small vessels that are harder to treat effectively. This trial aims to find out whether this new treatment option can help these patients better than current standard approaches.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive a catheter procedure where doctors use the new Prevail Drug-Coated Balloon to treat your blocked heart artery. After the procedure, you'll have follow-up visits with blood tests, heart imaging, and clinical assessments at regular intervals over the next 5 years to monitor how well the treatment is working and check for any side effects.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
United States